Chemotherapy-Related Cognitive Dysfunction

被引:0
|
作者
Jeffrey S. Wefel
Sanne B. Schagen
机构
[1] MD Anderson Cancer Center,Department of Neuro
[2] Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital,Oncology
关键词
Cognition; Chemotherapy; Neurotoxicity;
D O I
暂无
中图分类号
学科分类号
摘要
Many cancer patients develop treatment-related cognitive dysfunction that affects their quality of life and can result in diminished functional independence. There is an emerging body of transdisciplinary research demonstrating that chemotherapeutic agents can produce neurobiological changes within the brain, which are associated with a constellation of cognitive changes that can result in decreased quality of life and functional independence. The increased incidence of cancer, coupled with longer survival times, has resulted in larger numbers of cancer survivors who are struggling with this neurotoxicity. This review summarizes the neuropsychological findings in patients with breast and brain cancer who receive systemic chemotherapy as well as the recent animal and imaging research elucidating the mechanisms by which these therapies impact brain structure, function, and consequent behavior.
引用
收藏
页码:267 / 275
页数:8
相关论文
共 50 条
  • [1] Chemotherapy-Related Cognitive Dysfunction
    Wefel, Jeffrey S.
    Schagen, Sanne B.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2012, 12 (03) : 267 - 275
  • [2] Erratum to: Chemotherapy-Related Cognitive Dysfunction
    Jeffrey S. Wefel
    Sanne B. Schagen
    Current Neurology and Neuroscience Reports, 2012, 12 (3) : 340 - 340
  • [3] Chemotherapy-related cognitive impairment and kidney dysfunction
    Simeoni, Mariadelina
    Mulholland, Michele M.
    Workeneh, Biruh T.
    Capasso, Anna
    Hafez, Gaye
    Liabeuf, Sophie
    Malyszko, Jolanta
    Mani, Laila-Yasmin
    Trevisani, Francesco
    De, Ananya
    Wagner, Carsten A.
    Massy, Ziad A.
    Unwin, Robert
    Capasso, Giovambattista
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025, 40 : ii54 - ii63
  • [4] An Overview of Chemotherapy-Related Cognitive Dysfunction, or 'Chemobrain'
    Moore, Halle C. F.
    ONCOLOGY-NEW YORK, 2014, 28 (09): : 797 - 804
  • [5] COGNITIVE-BEHAVIORAL MANAGEMENT OF CHEMOTHERAPY-RELATED COGNITIVE DYSFUNCTION
    Ferguson, Robert J.
    ANNALS OF BEHAVIORAL MEDICINE, 2011, 41 : S142 - S142
  • [6] TREATMENT FOR CHEMOTHERAPY-RELATED COGNITIVE DYSFUNCTION: REVIEW OF THE LITERATURE
    Meyers, O., I
    VALUE IN HEALTH, 2015, 18 (03) : A190 - A190
  • [7] An Update on Cancer- and Chemotherapy-Related Cognitive Dysfunction: Current Status
    Janelsins, Michelle C.
    Kohli, Sadhna
    Mohile, Supriya G.
    Usuki, Kenneth
    Ahles, Tim A.
    Morrow, Gary R.
    SEMINARS IN ONCOLOGY, 2011, 38 (03) : 431 - 438
  • [8] Chemotherapy-related cognitive dysfunction: current animal studies and future directions
    Seigers, R.
    Schagen, S. B.
    Van Tellingen, O.
    Dietrich, J.
    BRAIN IMAGING AND BEHAVIOR, 2013, 7 (04) : 453 - 459
  • [9] A clinical trial of ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction
    Barton, D
    Loprinzi, C
    Fitch, T
    Hoff, K
    Basham, C
    Novotny, P
    Sloan, J
    Carpenter, L
    ONCOLOGY NURSING FORUM, 2005, 32 (01) : 178 - 178
  • [10] Chemotherapy-related cognitive dysfunction: current animal studies and future directions
    R. Seigers
    S. B. Schagen
    O. Van Tellingen
    J. Dietrich
    Brain Imaging and Behavior, 2013, 7 : 453 - 459